drugset / Trial / NCT00455143

Cognitive Protection - Dexmedetomidine and Cognitive Reserve

NCT00455143 ↗

Phase 4 Terminated 27 enrolled Icahn School of Medicine at Mount Sinai
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a pilot study to evaluate the effect of dexmedetomidine in the prevention of delirium in non-cardiac surgical patients. The preliminary data regarding the effect of dexmedetomidine on delirium comes from a study underway at Stanford. We propose to randomize fifty patients into two different protocols, one using dexmedetomidine until PACU discharge (hip replacement) and the other using dexmedetomidine for 24 hours in a monitored setting.

Timeline

Start
2006-09
Primary completion
2009-04
Completion
2009-04

Outcome

Outcome not reported

Stopped (Business): “Pilot study initiated to provide support data for main grant GCO 06-0217 funded. only baseline characteristic data collected. no results for this study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — —